baber/WOPTO huggingface dataset:
Patent CA-3092104-A1 (CA)
Title: Compression molding device of parts in composite material starting from plates in composite with a thermoplastic matrix
Inventor: CORVAGLIA STEFANO GIUSEPPE
IPC: B29C43/32
Filed: 2020-09-01
Abstract: A compression molding device configured for the production of a part in composite material starting from a plate in composite with a thermoplastic matrix is described; the device comprises: a fixed support structure; an upper half-die provided with a first contoured surface corresponding to the profile of an upper surface of the part to be made; a lower half-die provided with a second contoured surface corresponding to the profile of a lower surface of the part to be made; holding means carried by the support structure and configured to hold the plate in a position interposed between the half-dies; and moving means for moving at least one of the half-dies from and towards the plate; the holding means comprise two or more releasable grippers gripping by friction distinct portions of the peripheral edge of the plate and configured to completely release or allow the complete release of the plate itself when the latter is compressed between the half-dies during molding.
Patent CA-3094421-A1 (CA)
Inventor: GROENENDAAL WILLEMIJN
IPC: A61B5/0402
Filed: 2019-03-13
Abstract: A method for detecting a respiratory event of a subject comprises: receiving a bio-impedance measurement signal (S2) dependent on respiratory action from the subject; extracting (306) at least one time- sequence of the bio-impedance measurement signal (S2); and for each extracted time-sequence: comparing (308) the bio-impedance measurement signal (S2) with each of a plurality of machine learning models in an ensemble of machine learning models to form a set of predictions of occurrence of a respiratory event, wherein each prediction is based on comparing the bio-impedance measurement signal (S2) with one machine learning model, wherein each model correlates features of time-sequences of a bio-impedance measurement signal (S2) with presence of a respiratory event and wherein each model is trained on a unique data set of training time- sequences; deciding (310) whether a respiratory event occurs in the extracted time-sequence based on the set of predictions.
Patent CA-3096367-A1 (CA)
Inventor: LIEBE TIMOTHY M
IPC: F16J15/44
Filed: 2019-03-26
Abstract: In accordance with one aspect of the present disclosure, a roller bearing seal assembly is provided that includes a seal case and a rotor having a unitary, one-piece construction. The rotor is connected to the seal case and is rotatable relative to the seal case about an axis. The seal case and rotor include interfering portions that limit axial separation of the rotor and the seal case. In one embodiment, the rotor and seal case include at least one snap-fit connection that permits the rotor and seal case to be readily assembled. The at least one snap-fit connection includes the interfering portions which inhibit axial separation of the rotor and seal case after the rotor and seal case have been assembled.
Patent CA-3097983-A1 (CA)
Inventor: CELENTANO MICHAEL J
IPC: G01N27/403
Filed: 2005-06-20
Abstract: ABRÉGÉ : un procédé pour mesurer une impédance parasitique dau moins une trace dune bande d'essai de biocapteur. La bande dessai de biocapteur comprend (i) une électrode de travail, (ii) une trace délectrode de travail, (iii) une trace de détecteur de travail, (iv) une contre-électrode, (v) une trace de contre-électrode, et (vi) une contre-trace de détecteur. Le procédé comprend (a) le placement sélectif dune résistance dune série avec la trace de détecteur de travail et la trace délectrode de travail pour former un circuit ayant une impédance comprenant limpédance connue de la résistance et une impédance de trace de détecteur de travail, ainsi quune impédance de trace délectrode de travail, (b) lapplication sélective dun stimulus afin de produire un courant qui traverse le circuit série, (c) la mesure du courant circulant dans le circuit série, et (d) lutilisation de la mesure actuelle pour calculer limpédance parasitique dau moins une trace dune bande dessai de biocapteur. Date reçue/Date Received 2020-11-03
Patent CA-3100956-A1 (CA)
Title: Full depth laser ophthalmic surgical system, methods of calibrating the surgical system and treatment methods using the same
Inventor: WANG JENNY
IPC: A61F9/009
Filed: 2019-07-30
Abstract: A full depth ophthalmic surgical system includes a femtosecond laser source and an optical coherence tomographer. The system is capable of performing surgical procedures along the entire length of the eye from the cornea to the retina. In one embodiment, the system uses a removeable focal point extension assembly to extend the reach of the focal point location of the laser beam to the vitreous humor of the eye. In another embodiment, the optical system of the ophthalmic surgical system is optimized to focus the laser beam and imaging light in the vitreous humor of the eye. For procedures performed posterior to the lens, a method for calibrating the full depth ophthalmic surgical system uses the focal zone of the optical coherence tomographer beam as a proxy for the focal zone of the femtosecond laser source to. The system can be used to perform treatment in the vitreous humor, including treating floaters and liquification of the vitreous humor.
Patent CA-3103880-A1 (CA)
Title: Four, ainsi qu'un procede d'agitation d'aliments contenus dans un recipient dispose dans la cavite de cuisson d'un tel four, et element agitateur destine a un tel four
Inventor: HIJMA HERMAN
IPC: B01F29/83
Filed: 2019-07-02
Abstract: L'invention concerne un four comprenant une cavité de cuisson, un élément d'agitation s'étendant, lors de l'utilisation, dans des aliments contenus dans un récipient disposé dans la cavité de cuisson, ainsi qu'un moyen d'entraînement destiné à fournir, lors de l'utilisation, un mouvement relatif entre l'élément d'agitation et le récipient. Le four comprend un dispositif de déplacement destiné à déplacer l'élément d'agitation, de l'extérieur de la cavité de cuisson, à travers une ouverture ménagée dans une paroi délimitant la cavité de cuisson, dans la cavité de cuisson, de même que, lors de l'utilisation, dans le récipient disposé dans la cavité de cuisson.
Patent CA-3104165-A1 (CA)
Title: Combined use of pertuzumab, trastuzumab, and docetaxel for treatment of her2-positive breast cancer
Inventor: ALAVATTAM SREEDHARA
IPC: A61K31/337
Filed: 2012-08-29
Abstract: Described herein is a use of Pertuzumab, in combination with Trastuzumab and Docetaxel, in the treatment of HER2-positive metastatic breast cancer without increasing cardiac toxicity. The combination is especially useful in HER2-positive metastatic breast cancer patients with a left ventricular ejection fraction (LVEF) of >50% pre-treatment who has not received prior chemotherapy or biologic therapy for their metastatic disease. The cardiac toxicity is left ventricular systolic dysfunction (LVSD), and the incidence of LVSD  after at least 15 cycles of Pertuzumab, Trastuzumab and Docetaxel is less than the incidence of LVSD in HER2-positive metastatic breast cancer patients treated with Trastuzumab and Docetaxel only. The treatment comprises withdrawal of administration of the Pertuzumab and Trastuzumab for at least 3 weeks if the patient has a drop in LVEF to less than 40%, or a LVEF of 40% to 45% with a 10% or greater absolute decrease below pre-treatment value, and resumption of administration of the Pertuzumab and Trastuzumab if the LVEF has recovered to greater than 45%, or to 40% to 45% associated with less than a 10% absolute decrease below pre-treatment value.
Patent CA-3104466-A1 (CA)
Inventor: INOUE YASUFUMI
IPC: B05B1/00
Filed: 2019-09-30
Abstract: In order to provide a spray head for a liquefied fire-extinguishing agent, the spray head having excellent vaporization characteristics and and excellent characteristics for scattering the liquefied fire-extinguishing agent, and being configured so that it is possible to increase the fire-extinguishing range that can be covered by a single spray head and also possible to raise the rate at which noise is reduced, this spray head 1 for a liquefied fire-extinguishing agent comprises a spray head body 2 to which there is connected piping for supplying a liquefied fire-extinguishing agent, an orifice plate 3 that is installed in the spray head body 2 and that has formed therein orifices 31 through which the liquid fire-extinguishing agent passes, a block-shaped porous member 4 installed in an outlet part of the orifices 31, and a baffle plate 5 installed so as to be in contact with an end surface of the porous member 4 that is on the side opposite from the outlet part of the orifices 31, the baffle plate 5 being configured so as to cover at least a projected area portion of a circumscribed circle 31c of the orifices 31 at the end surface of the porous member 4, and moreover being configured so that the liquefied fire-extinguishing agent is released through a gap 6 between the spray head body 2 and the baffle plate 5.
Patent CA-3104576-A1 (CA)
Inventor: MORAVEC MIROSLAV
IPC: A61B5/25
Filed: 2019-07-03
Abstract: The recording electrode (1) for measuring the electrophysiological signal from biological tissue is particularly suitable for use in magnetic stimulation. This recording electrode is provided with a contact area (2) designed to come into contact with biological tissue by direct contact or through electro-conductive gel to facilitate sensing of the electrophysiological signal from the biological tissue to the contact area (2), where the contact area (2) is electrically connected to the output of the recording electrode (1) for conducting the electrophysiological signal for further processing. The contact area (2) of the recording electrode (1) is divided into at least two separate contact areas (3) electrically separated from each other, each separate contact area (3) being connected to the output of the recording electrode (1) via its own resistor (4), whose electrical resistance is at least 100 O, while the resulting resistance of all resistors connecting the individual separate contact areas (3) with the output of the recording electrode (1), as measured between the biological tissue and the output of the recording electrode (1), is at least 50 O, which corresponds to at least half the size of the impedance of the biological tissue in magnetic stimulation.
Patent CA-3104713-A1 (CA)
Inventor: GRIGORE GEORGE
IPC: H04N21/8541
Filed: 2020-03-27
Abstract: Le système génère un affichage fournissant des informations de scénario. L'affichage comprend, par exemple, une pluralité d'identifiants de scénario, une pluralité d'indicateurs de période et une pluralité d'indicateurs d'épisode. Les indicateurs d'épisode indiquent un épisode comprenant un segment du scénario correspondant à un identifiant de scénario. Le système peut recevoir une entrée d'utilisateur sélectionnant un scénario, ou encore filtrant un scénario existant pour adapter les informations affichées plus étroitement à un scénario d'intérêt. Le système met à jour l'affichage pour refléter chacun des segments dans les épisodes correspondant à l'identifiant de scénario sélectionné. L'affichage peut comprendre une grille, les identifiants de scénario étant agencés le long d'un axe et les indicateurs de période disposés le long d'un axe différent. Le système peut traiter des métadonnées pour déterminer des scénarios et filtrer quelles informations sont affichées en fonction d'une entrée d'utilisateur, des métadonnées, ou des deux. Les scénarios comprennent, par exemple, des personnages, des lieux, des intrigues, des équipes, des joueurs ou d'autres attributs.
Patent CA-3105125-A1 (CA)
Title: Twist and flip closure
Inventor: MIGAS JEREMIAH
IPC: B65D55/16
Filed: 2019-07-03
Abstract: A flip-top closure includes first and second closure portions. The first closure portion (12) includes a polymeric top wall portion (22), a sealing mechanism (24), and a polymeric annular skirt portion (26) depending from the top wall portion. The skirt portion includes an internal thread formation (40) for mating with a container. The second closure portion (14) includes a polymeric tamper-evident band depending from and being partially detachably connected to the skirt portion by a frangible connection (36). The frangible connection extends partially around the periphery of the closure.  The first and second closure portions are attached via at least one hinge (16a, 16b). The at least one hinge assists in moving the closure between an open and closed positions after the frangible connection has been broken.
Patent CA-3107297-A1 (CA)
Inventor: JONES DANIEL D
IPC: G06F16/90
Filed: 2021-01-28
Abstract: Des appareils, méthodes, progiciels et systèmes sont décrits pour une interface de requête de protection des données. Un appareil comprend un processeur et une mémoire stockant le code exécutable par le processeur pour recevoir, à laide dune interface de requête, une requête dune tierce partie pour vérifier les données de nature délicate associées à un utilisateur ou une utilisatrice, analyser la requête pour déterminer un type des données de nature délicate de lutilisateur ou de lutilisatrice à vérifier, et générer une réponse de vérification à la requête en fonction dune vérification des données de lutilisateur ou lutilisatrice liées au type de données de nature délicate à vérifier sans divulguer lesdites données à la tierce partie.
Patent CA-3108832-A1 (CA)
Title: Synthetic peptide for detecting hiv-1
Inventor: CUI PENG
IPC: G01N33/569
Filed: 2019-08-06
Abstract: The present disclosure relates to the field of medical diagnosis, and specifically relates to a synthetic peptide for detecting HIV-1. The synthetic peptide is obtained from mutating the amino acid sequence as shown in SEQ ID NO: 1. The synthetic peptide can better detect anti-HIV-1 antibodies, and can better avoid potential "false negative" and "false positive" results.
Patent CA-3110722-A1 (CA)
Inventor: Surcouf Andre Jean-Marie
IPC: H04L12/803
Filed: 2019-08-30
Abstract: Systems, methods, and computer-readable media for reducing distributed storage operation latency using segment routing. In some examples, a method can involve receiving, from a client, a message identifying an intent to store or retrieve data on a distributed storage environment, and sending to the client a segment routing (SR) list identifying storage node candidates for storing or retrieving the data. The method can involve steering a data request from the client through a path defined by the SR list based on a segment routing header (SRH) associated with the request, the SRH being configured to steer the request through the path until a storage node from the storage node candidates accepts the request. The method can further involve sending, to the client device, a response indicating that the storage node has accepted the request and storing or retrieving the data at the storage node that accepted the request.
Patent CA-3111295-A1 (CA)
Title: Cartouche de fluide pour pulverisateur de plusieurs composants
Inventor: ROSS DANIEL P
IPC: B05B7/12
Filed: 2019-10-25
Abstract: Cartouche de fluide pour un pulvérisateur de plusieurs composants conçue pour recevoir des premier et second matériaux composants et évacuer l'air du pulvérisateur et fournir les premier et second matériaux composants et évacuer l'air vers une chambre de mélange pour pulvérisation. La cartouche de fluide comprend un corps de cartouche, des chemins d'écoulement de matériau s'étendant d'une seconde extrémité à un trou de cartouche, et un chemin d'évacuation s'étendant de la seconde extrémité au trou de cartouche. Des clapets anti-retour de fluide sont disposés dans les chemins d'écoulement de matériau et le chemin d'évacuation pour empêcher un reflux hors de la cartouche de fluide. Des joints latéraux sont disposés dans les chemins de matériau et sont pré-chargés pour s'étendre dans le trou de cartouche et entrer en prise avec une chambre de mélange à l'intérieur du trou de cartouche.
Patent CA-3111563-A1 (CA)
Title: Modified peptide fragments of cav-1 protein and the use thereof in the treatment of fibrosis
Inventor: CHRISTENSEN DALE
IPC: C07K7/06
Filed: 2019-09-10
Abstract: Provided herein are compositions comprising modified caveolin-1 (Cav-1) peptides. Further provided are methods of using the modified Cav-1 peptides for the treatment of lung infections or acute or chronic lung injury, particularly lung fibrosis.
Patent CA-3111595-A1 (CA)
Inventor: CHAKRAVARTY NARASIMHACHARY NALLANA
IPC: G06K9/66
Filed: 2019-09-19
Abstract: A system and method of identifying and tracking objects comprises registering an identity of a person who visits an area designated for holding objects, capturing an image of the area designated for holding objects, submitting a version of the image to a deep neural network trained to detect and recognize objects in images like those objects held in the designated area, detecting an object in the version of the image, associating the registered identity of the person with the detected object, retraining the deep neural network using the version of the image if the deep neural network is unable to recognize the detected object, and tracking a location of the detected object while the detected object is in the area designated for holding objects.
Patent CA-3111794-A1 (CA)
Inventor: KUMAR MANOJ
IPC: F16L58/00
Filed: 2021-03-11
Abstract: Il est décrit une composition et une méthode pour atténuer la formation ou lactivité dun biofilm associé à la corrosion sur des surfaces métalliques de pipelines. Les pipelines sont premièrement traités avec des racleurs (c.-à-d. racleurs bi-di) pour le retrait ou la perturbation du biofilm, suivi du traitement microbien (c.-à-d. application dune composition microbicide). La composition microbicide comprend au moins un alcool, un inhibiteur de corrosion, un agent de surface, un biocide et une nanoparticule à base de lignine. La nanoparticule à base de lignine est fonctionnalisée avec un agent de fonctionnalisation damine. La présente composition et méthode est écologique, car une faible concentration est suffisante. De plus, un dosage régulier nest pas requis pour un contrôle disocyanate de méthyle.
Patent CA-3112171-A1 (CA)
Inventor: SALUJA ASHOK K
IPC: C07J73/00
Filed: 2019-09-12
Abstract: The invention provides a compound of formula (I): or a pharmaceutically acceptable salt thereof for the prophylactic or therapeutic treatment of fibrosis, nonalcoholic fatty liver disease (NAFLD) or nonalcoholic steatohepatitis (NASH).
Patent CA-3114134-A1 (CA)
Title: Construction d'une petite maison sur roues
Inventor: SCHULTZ FRED
IPC: B60P3/32
Filed: 2019-10-16
Abstract: L'invention concerne un bâtiment mobile construit sur une remorque, lequel bâtiment comprend : une remorque à roues sur laquelle le bâtiment est construit, un plancher et une pluralité de parois fixées à la remorque ; et une structure de toit, des côtés externes des parois étant consolidés avec un revêtement fixé aux parois, le revêtement s'étendant à partir d'une base du bâtiment et étant fixé à la structure de toit.
Patent CA-3115163-A1 (CA)
Title: Pharmaceutical compositions comprising bispecific anti-cd37 antibodies
Inventor: OOSTINDIE SIMONE
IPC: A61P35/00
Filed: 2019-10-04
Abstract: The disclosure relates to pharmaceutical compositions comprising CD37-specific bispecific antibody molecules binding to different epitopes of the human CD37 antigen which bispecific antibody molecules have enhanced Fc-Fc interactions upon binding to CD37 on the cell surface. The disclosure also relates to use of these pharmaceutical compositions for the treatment of cancer and other diseases.
Patent CA-3115945-A1 (CA)
Title: Molecular markers in prostate cancer
Inventor: SMIT FRANCISCUS PETRUS
IPC: C12Q1/6886
Filed: 2012-05-09
Abstract: The present invention relates to a method for in vitro diagnosing prostate cancer in a human individual. The method includes determining the expression of TDRD1; and determining whether there is up regulation of expression of TDRD1 as compared to expression of TDRD1 in a sample from an individual without prostate cancer. The sample is prostate tissue, urine or a urine-derived sample. Up regulation of expression of TDRD1 indicates in vitro diagnosis of prostate cancer thereby providing said diagnosis of prostate cancer.
Patent CA-3118055-A1 (CA)
Inventor: CABOT ROSS
IPC: A24F40/10
Filed: 2019-10-31
Abstract: There is provided an aerosolised formulation comprising (i) water in an amount of at least 50 wt.% based on the aerosolised formulation; and (ii) at least one active agent comprising at least nicotine; and (iii) one or more cyclodextrins; wherein the aerosol has the following particle size distribution: a D50 of from 2 to 6pm, a D10 of at least 0.5pm and a DOO of no greater than 15pm.
Patent CA-3118265-A1 (CA)
Inventor: FETTERLY MATTHIEW
IPC: A63C13/00
Filed: 2021-05-13
Abstract: A device for adding traction to a snowshoe; the device includes a first plate, a second plate, at least one spike and at least one attachment means. The device is easily attached and detached from a snowshoe to provide traction thereto, allowing a wearer to walk on an inclined snow/icy surface. The first plate installs over the snowshoe and the second plate installs under the snowshoe. The first plate and the second plate attach together to secure the device to the snowshoe. In some embodiments, the first plate and the second plate include apertures and bolt(s) are used to fasten through the apertures and openings in a weave of the snowshoe to fasten the device thereto.
Patent CA-3121525-A1 (CA)
Title: Low sodium protein isolate
Inventor: CALMON LUCILE
IPC: A23J3/22
Filed: 2019-12-11
Abstract: The present invention pertains to a plant protein, including isolates and concentrates, preferably leguminous protein isolates, more preferably pea protein isolates characterized in that it contains less than 0,6% by dry weight of sodium on dry matter and below 1% by dry weight of calcium. The invention further relates to processes of extraction and purification of the plant proteins, including isolate and concentrate, preferably leguminous protein isolates, more preferably pea protein isolates of the invention. Finally, the invention also relates to the application of plant proteins, including isolate and concentrate, preferably leguminous protein isolates, more preferably pea protein isolates, of the invention, in the food, feed and pharmaceutical industries.
Patent CA-3121589-A1 (CA)
Title: Food or beverage product with agglomerated pea protein
Inventor: SCHMITT CHRISTOPHE JOSEPH ETIENNE
IPC: A23J3/14
Filed: 2019-11-20
Abstract: The present invention relates to a method of producing a food or beverage product, in particular to a method for forming agglomerated pea proteins in an ingredient composition. The invention also relates food or beverage product comprising agglomerated pea proteins.
Patent CA-3123734-A1 (CA)
Title: Filling material for treating chronic venous insufficiency and a corresponding insertion method
Inventor: FRANT MIIKKA
IPC: A61B17/12
Filed: 2019-12-13
Abstract: The present invention introduces a material, i.e. a device, which is insertable into a vein of a patient for treating e.g. chronic venous insufficiency. The device comprises inner (11, 24) and outer (12, 23) parts of a sheath, two-sidedly adhesive tubular material (22) with a supporting material (42) and protrusions (41), either a balong (21) or an inner protective film (33), and a control cable (14) for the insertion and extraction of the device along the vein. The supporting material may be compressed initially, and after removal of the outer part of the sheath, the supporting material with protrusions will expand towards the vein walls. After removal of the inner part of the sheath and the control cable, the treated vein area can be manually pressed on top of the skin, thus closing the vein through inner and outer adherence of the material. The protrusions may have a barbed shape.